Access Now: AORN COVID-19 Clinical Support

Archive August 2019 XX, No. 8

Running on Empty

Don't let the drug shortage leave you hung out to dry. Take these 5 steps to ensure limited supplies of essential medications never impact patient care.

Daniel Cook

Daniel Cook, Editor-in-Chief


GOOD TO THE LAST DRIP A historic storm isn't the only reason critical fluids and drugs are seemingly in constant short supply.

In the early morning hours of Sept. 20, 2017, Hurricane Maria slammed into the southeast coast of Puerto Rico and tracked across the island with maximum sustained winds of 155 mph, leaving a trail of catastrophic destruction in its wake. The Category 4 cyclone knocked out the island’s power grid that ran the manufacturing plants of Baxter International, a major supplier of IV saline bags used by healthcare professionals across the United States to administer intravenous drugs. Baxter’s plants were offline for months, causing a severe shortage of 50 ml and 100 ml IV bags. Production volume of the bags is only now reaching pre-Maria levels.

The historic hurricane was an obvious event that slowed the flow of IV fluid to a trickle, but other causes of drug shortages are more subtle — and more persistent. Pharmaceutical companies hit with FDA warnings for failing to comply with quality medication production standards has led to massive recalls and forced some manufacturing plants to shutter, putting more strain on other drug producers that might not have the capacity or resources to fill the void. In September 2015, Pfizer acquired Hospira in a major merger involving companies that make a vast majority of injectable medications. Pfizer inherited Hospira’s manufacturing plants, which were wrought with quality control problems, and implemented a remediation plan 2 years ago. But production problems, unbelievably and frustratingly, persist.

In general, the generic injectables market remains fragile. There isn’t much of a profit incentive — generics are expensive to make and inexpensive to buy — for companies to produce the medications. Big Pharma is big businesses, first and foremost, and companies are opting to focus their manufacturing resources on more lucrative brand-name therapeutics.

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Proven Strategies for Managing PPE

Facilities are getting creative to maintain adequate levels of personal protective equipment despite nationwide shortages.

The Perks of Prefilled Syringes

Predrawn meds are a convenient, safe and economical option.

The True Price of Prefilled Syringes

Focusing too heavily on the upfront costs of premixed medications can come back to hurt you in surprising ways.